Glissmann, head of asset allocation research at Goldman Sachs, on the outperformance of European and Chinese stocks over the ...

There's no question the financial services industry is home to some of the world's most dominant businesses. One such company ...

Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT – Get Free Report) shares reached a new 52-week low on Monday after The Goldman Sachs Group lowered their price target on the stock from $29.00 to $15.00. The ...

Expectations of a banner year in dealmaking have not yet materialized due to worries about inflation and uncertainties over U ...

Investors might be surprised to learn that in the past five years, shares of Goldman Sachs (NYSE: GS) have soared 186%.

Silence Therapeutics plc (NASDAQ:SLN – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the ...

American Airlines Group (NASDAQ:AAL – Free Report) had its price objective lowered by JPMorgan Chase & Co. from $30.00 to $26 ...

Couchbase (NASDAQ:BASE – Free Report) had its target price trimmed by The Goldman Sachs Group from $18.00 to $16.00 in a ...

Relay Therapeutics (NASDAQ:RLAY – Free Report) had its price objective lowered by The Goldman Sachs Group from $20.00 to ...

This gold miner could be a top pick for investors wanting exposure to this side of the market. The post Goldman Sachs says ...